1 Day
Source:
معلومات مباشر
Ramida Affirms Saudi Pharma Project
Ramida, the 10th of Ramadan Pharmaceuticals Industries Company, has confirmed its expansion plans in the Saudi market through the establishment of a pharmaceutical factory in collaboration with LV Pharma. This move aligns with its strategic efforts previously announced in June 2026, after LV Pharma increased its stake in Ramida to 31.49% by purchasing approximately 167 million shares valued at around 846.5 million Egyptian pounds. The company will announce full details once all the necessary implementation procedures for the project are completed.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)